BIOLASE, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Concentrations (Tables)

Concentrations (Tables)

9 Months Ended

Sep. 30, 2015

Risks And Uncertainties [Abstract]

Summary of Net Revenue from Various Products

Revenue from the Company’s products for the three and nine months ended September 30, 2015 and 2014 are as follows:

	Three Months Ended								Nine Months Ended
	September 30								September 30
	2015				2014				2015				2014
Laser systems		65.3	%			57.9	%			65.2	%			60.2	%
Imaging systems		6.4	%			11.0	%			4.7	%			9.5	%
Consumables and other		13.1	%			12.6	%			15.5	%			13.6	%
Services		14.9	%			18.2	%			14.1	%			16.3	%
License fees and royalties		0.3	%			0.3	%			0.5	%			0.4	%
Total revenue		100.0	%			100.0	%			100.0	%			100.0	%